Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The Eye and the Brain: Photonic Devices in Neuro-Ophthalmology.
Associations Between Neuromuscular Fatigue, Anxiety, and Peripheral Biomarkers of Neuronal Injury, Inflammation, and Mitochondrial Dysfunction in Treatment-Naïve Relapsing-Remitting Multiple Sclerosis.
Gaining biological insights through supervised data visualization.
TAAR Immunopharmacology.
Polyneuropathy, Organomegaly, Endocrinopathy, M-Protein, and Skin Changes (POEMS) Syndrome With Characteristic Muscle Biopsy Findings and Without M-Protein.
Assessment of Changes in Postural Stability and Load Distribution in Patients With Multiple Sclerosis After 12 Weeks of Self-Paced Exercises Programmed by a Physiotherapist: A Prospective Cohort Study.
Microbiome-derived metabolites from vitamin B2 and B9 pathways modulate MAIT cells from multiple sclerosis patients.
Guillain-Barré syndrome following meningitis after cupping therapy: a case report.
Real-World Data for Safety Studies: Challenges and Opportunities From the Italian Multiple Sclerosis and Related Disorders Register.
Trigeminal root dislocation subtends focal demyelination of primary trigeminal afferents in patients with trigeminal neuralgia.
Fus-depleted oligodendrocytes reduce neuronal damage and Alzheimer's disease progression in the AppNL-G-F mouse.
Whole-body irradiation causes long-term impairments in the maintenance and function of naïve CD4 T cells specific for self- and non-self-antigens.
Non-Pharmacological Constipation Management in People With Neurodegenerative Disease: A Scoping Review.
Long-Term Clinical and Psychological Efficacy and Safety of Ocrelizumab in People With Multiple Sclerosis: A Real-World Longitudinal Study.
Optimizing Identification and Management of Depression in Neurological Diseases: A Narrative Review and Expert Perspective.
Correction to: Identification of diagnostic biomarkers for relapsing-remitting multiple sclerosis in plasma by mass spectrometry-based proteomics.
Familial occurrence of multiple sclerosis - current state of knowledge.
Differences in disease burden between neuromyelitis optica spectrum disorder and multiple sclerosis in South China.
Comment on "Efficacy and safety of conventional immunosuppressant therapies in elderly patients with Neuromyelitis optica spectrum disorder: A target trial emulation study".
Challenges and Innovation for Diagnosing and Treatment of Secondary Progressive Multiple Sclerosis.
Reversible area postrema syndrome in a patient with mutation mimicking neuromyelitis optica spectrum disorder.
Microglia-driven neuroinflammatory signaling in neurodegeneration: mechanisms and therapeutic opportunities.
Early Developmental Neuronal Activity Impacts Oligodendrocyte Differentiation Through AMPA Receptors.
Wearable Ultrasound Devices for Continuous Bladder Monitoring: Emerging Utility and Current Limitations in Neurourology.
A novel cyclic peptide that blocks human autoimmune antibodies for the treatment of Multiple sclerosis.

Pages